Post-earnings recap
Reported
Wed, Jul 31, 2019
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
ACADIA Pharmaceuticals reported a loss per share of $0.38, which was better than expected, resulting in a slight positive surprise. However, the stock reacted negatively, declining by 1.68%. The lack of revenue figures and management commentary may have contributed to investor uncertainty.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.38 | N/A | +15.50% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.